Delcath Systems to Present at BTIG Healthcare Conference in February 2024
Delcath Systems (Nasdaq: DCTH), an interventional oncology company specializing in liver cancer treatments, has announced...
Delcath Systems (Nasdaq: DCTH), an interventional oncology company specializing in liver cancer treatments, has announced...
PBC is a type of chronic liver disease in which the small bile ducts in the liver become injured and...
FAIRFIELD, N.J. , Jan. 23, 2025 /PRNewswire/ -- Today, American Liver Foundation (ALF) and the U.S. Department of Veterans Affairs...
Two separate phase 3 trials show that semaglutide improved fatty liver disease and reduced hospitalizations related to cardiovascular risk in...
What You Should Know: – Siemens Healthineers, a leading global medical technology company operating in over 180 countries, is pioneering...
New Delhi, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The global liver fibrosis treatment market was valued at USD 17.51 billion...